Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sofosbuvir plus Ribavirin for HCV Genotype 4 in Egypt
NCT01713283Phase 2Completed
- Sponsor
- Gilead Sciences
- Start
- Oct 2012
- Primary completion
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sofosbuvir in chronic hepatitis C (CHC), sponsored by Gilead Sciences. Started Oct 2012; status: completed.
02
Drugs
sofosbuvir
03
Conditions
chronic hepatitis C (CHC)
Beyond the preview
Go deeper on NCT01713283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01713283.